ALL:NYSE

Allstate (ALL) is trading at $207.69, just below its 20‑day SMA of $208.80 but comfortably above the 50‑day ($205.02) and 200‑day ($203.34) averages, indicating a still‑bullish price bias. The RSI sits at 49, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure. Volume trends are decreasing, and the stock is hovering near a support zone around $198.17 with resistance near $215.51, while 30‑day volatility is moderate at 27.8% and beta is low at 0.43, reflecting limited market‑wide swings. Fundamentally, ALL trades at a trailing PE of 5.46 versus an industry average of 17.38, a price‑to‑book of 1.89, and a robust ROE of 39.5%, underscoring strong profitability and a clear valuation gap. The dividend yield of 2.08% is backed by a modest payout ratio of 10.5% and solid free cash flow, making the payout sustainable.
Recent analyst commentary adds momentum: Wells Fargo lifted its price target to $228 and maintained a Buy rating, citing easing catastrophe losses and an improving earnings outlook, while Zacks highlighted ALL as a top cheap stock for 2026. These qualitative catalysts, combined with the quantitative undervaluation and resilient cash generation, suggest upside potential and a compelling entry point for investors.